MEDAPP S.A. ZY -10 (WQ1) - Net Assets
Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has net assets worth €26.82 Million EUR (≈ $31.35 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€39.88 Million ≈ $46.62 Million USD) and total liabilities (€13.06 Million ≈ $15.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read MEDAPP S.A. ZY -10 balance sheet liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €26.82 Million |
| % of Total Assets | 67.25% |
| Annual Growth Rate | 1.52% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 6.35 |
MEDAPP S.A. ZY -10 - Net Assets Trend (2021–2025)
This chart illustrates how MEDAPP S.A. ZY -10's net assets have evolved over time, based on quarterly financial data. Also explore WQ1 total asset value for the complete picture of this company's asset base.
Annual Net Assets for MEDAPP S.A. ZY -10 (2021–2025)
The table below shows the annual net assets of MEDAPP S.A. ZY -10 from 2021 to 2025. For live valuation and market cap data, see WQ1 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €26.82 Million ≈ $31.35 Million |
-7.01% |
| 2024-12-31 | €28.84 Million ≈ $33.71 Million |
+7.88% |
| 2023-12-31 | €26.73 Million ≈ $31.25 Million |
-1.68% |
| 2022-12-31 | €27.19 Million ≈ $31.79 Million |
+7.70% |
| 2021-12-31 | €25.25 Million ≈ $29.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MEDAPP S.A. ZY -10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1414.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €26.72 Million | 111.70% |
| Total Equity | €23.92 Million | 100.00% |
MEDAPP S.A. ZY -10 Competitors by Market Cap
The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aeris Environmental Ltd
AU:AEI
|
$6.80 Million |
|
Sahakol Equipment Public Company Limited
BK:SQ
|
$6.81 Million |
|
Home Pottery Public Company Limited
BK:HPT
|
$6.81 Million |
|
Ho Wah Genting Bhd
KLSE:9601
|
$6.81 Million |
|
DGB Group NV
AS:DGB
|
$6.80 Million |
|
LCL Resources Ltd
AU:LCL
|
$6.80 Million |
|
Safello Group AB
ST:SFL
|
$6.80 Million |
|
YLI Holdings Bhd
KLSE:7014
|
$6.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDAPP S.A. ZY -10's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 26,075,000 to 23,924,000, a change of -2,151,000 (-8.2%).
- Net loss of 2,151,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.15 Million | -8.99% |
| Total Change | €- | -8.25% |
Book Value vs Market Value Analysis
This analysis compares MEDAPP S.A. ZY -10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.28x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.10 | €0.03 | x |
| 2022-12-31 | €0.11 | €0.03 | x |
| 2023-12-31 | €0.10 | €0.03 | x |
| 2024-12-31 | €0.10 | €0.03 | x |
| 2025-12-31 | €0.10 | €0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDAPP S.A. ZY -10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -56.04%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.67x
- Recent ROE (-8.99%) is below the historical average (0.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 16.33% | 32.44% | 0.39x | 1.29x | €1.60 Million |
| 2022 | 2.24% | 9.05% | 0.21x | 1.18x | €-2.11 Million |
| 2023 | -13.01% | -54.52% | 0.16x | 1.49x | €-5.53 Million |
| 2024 | 7.81% | 28.28% | 0.18x | 1.55x | €-571.50K |
| 2025 | -8.99% | -56.04% | 0.10x | 1.67x | €-4.54 Million |
Industry Comparison
This section compares MEDAPP S.A. ZY -10's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $458,323,792
- Average return on equity (ROE) among peers: -84.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDAPP S.A. ZY -10 (WQ1) | €26.82 Million | 16.33% | 0.49x | $6.80 Million |
| YIDU TECH INC. DL -00002 (0EL) | $4.01 Billion | -19.02% | 0.18x | $673.03 Million |
| CERTIVE SOLUTIONS INC. (5CE) | $-9.11 Million | 0.00% | 0.00x | $253.72K |
| UPHEALTH INC (5XV) | $333.84 Million | -102.15% | 0.71x | $5.44 Million |
| IQ-AI LTD. LS -01 (5Y1) | $94.92K | -657.17% | 6.59x | $123.35K |
| NIGHTINGALE HEALTH EO 1 (7XE) | $97.36 Million | -18.57% | 0.10x | $35.64 Million |
| TRELLUS HEALTH LS -0006 (85Q) | $35.27 Million | -16.73% | 0.04x | $215.06K |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $5.83 Million | -68.78% | 0.33x | $916.43K |
| DocCheck AG (AJ91) | $18.59 Million | 9.11% | 0.26x | $78.14 Million |
| CompuGroup Medical SE & Co. KGaA (COP) | $28.87 Million | 34.15% | 3.77x | $1.17 Billion |
| KNEAT.COM INC. (FOBK) | $65.02 Million | -3.61% | 0.87x | $303.17 Million |
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more